MY129518A - Beta-agonists treating endometriosis or infertility, or improving fertility - Google Patents

Beta-agonists treating endometriosis or infertility, or improving fertility

Info

Publication number
MY129518A
MY129518A MYPI20004608A MYPI20004608A MY129518A MY 129518 A MY129518 A MY 129518A MY PI20004608 A MYPI20004608 A MY PI20004608A MY PI20004608 A MYPI20004608 A MY PI20004608A MY 129518 A MY129518 A MY 129518A
Authority
MY
Malaysia
Prior art keywords
infertility
agonists
beta
treating endometriosis
improving fertility
Prior art date
Application number
MYPI20004608A
Other languages
English (en)
Inventor
William J Bologna
Dominique De Ziegler
Howard L Levine
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of MY129518A publication Critical patent/MY129518A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MYPI20004608A 1999-10-05 2000-10-03 Beta-agonists treating endometriosis or infertility, or improving fertility MY129518A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25

Publications (1)

Publication Number Publication Date
MY129518A true MY129518A (en) 2007-04-30

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20004608A MY129518A (en) 1999-10-05 2000-10-03 Beta-agonists treating endometriosis or infertility, or improving fertility

Country Status (28)

Country Link
EP (1) EP1220667B1 (https=)
JP (2) JP2003510354A (https=)
KR (1) KR100738724B1 (https=)
CN (1) CN1218694C (https=)
AR (1) AR028487A1 (https=)
AT (1) ATE271860T1 (https=)
AU (1) AU780736B2 (https=)
BR (1) BR0014548A (https=)
CA (1) CA2385974C (https=)
CO (1) CO5251423A1 (https=)
DE (1) DE60012554T2 (https=)
DK (1) DK1220667T3 (https=)
ES (1) ES2223581T3 (https=)
GE (1) GEP20043313B (https=)
HK (1) HK1044120B (https=)
HU (1) HU225990B1 (https=)
IL (2) IL148784A0 (https=)
MA (1) MA25501A1 (https=)
MX (1) MXPA02003453A (https=)
MY (1) MY129518A (https=)
NO (1) NO329663B1 (https=)
NZ (1) NZ518429A (https=)
PE (1) PE20010742A1 (https=)
PT (1) PT1220667E (https=)
TR (1) TR200200899T2 (https=)
TW (1) TWI280877B (https=)
UA (1) UA74168C2 (https=)
WO (1) WO2001024788A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (en) 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
CN107260745A (zh) * 2010-03-22 2017-10-20 利普生物药剂公司 用于抗孕酮的非毒性递送的组合物和方法
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
CA2872644A1 (en) 2012-05-31 2013-12-05 Allergan Pharmaceuticals International Limited Formulations and methods for vaginal delivery of antiprogestins
US9545411B2 (en) 2012-11-02 2017-01-17 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions
CN116172995A (zh) * 2023-01-17 2023-05-30 浙江大学医学院附属妇产科医院 一种沙丁胺醇在制备治疗子宫内膜异位症的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
HUP0203050A2 (hu) 2003-02-28
CA2385974C (en) 2010-01-26
WO2001024788A2 (en) 2001-04-12
BR0014548A (pt) 2002-06-04
HK1044120B (en) 2004-12-17
ATE271860T1 (de) 2004-08-15
HUP0203050A3 (en) 2006-02-28
AU780736B2 (en) 2005-04-14
CO5251423A1 (es) 2003-02-28
DE60012554D1 (de) 2004-09-02
CN1377264A (zh) 2002-10-30
ES2223581T3 (es) 2005-03-01
HU225990B1 (en) 2008-02-28
PT1220667E (pt) 2004-11-30
IL148784A0 (en) 2002-09-12
TR200200899T2 (tr) 2002-07-22
MA25501A1 (fr) 2002-07-01
DE60012554T2 (de) 2005-11-24
AR028487A1 (es) 2003-05-14
KR100738724B1 (ko) 2007-07-12
CA2385974A1 (en) 2001-04-12
DK1220667T3 (da) 2004-12-06
PE20010742A1 (es) 2001-07-19
MXPA02003453A (es) 2002-08-20
UA74168C2 (uk) 2005-11-15
GEP20043313B (en) 2004-03-10
TWI280877B (en) 2007-05-11
NO20021591D0 (no) 2002-04-04
JP2010018639A (ja) 2010-01-28
IL148784A (en) 2006-12-31
EP1220667B1 (en) 2004-07-28
WO2001024788A3 (en) 2001-12-06
NO329663B1 (no) 2010-11-29
NZ518429A (en) 2004-02-27
NO20021591L (no) 2002-05-28
CN1218694C (zh) 2005-09-14
JP2003510354A (ja) 2003-03-18
EP1220667A2 (en) 2002-07-10
AU7525000A (en) 2001-05-10
HK1044120A1 (en) 2002-10-11
KR20020062285A (ko) 2002-07-25

Similar Documents

Publication Publication Date Title
MY129518A (en) Beta-agonists treating endometriosis or infertility, or improving fertility
WO2000056296A3 (en) Compositions for improving fertility
AU2610799A (en) Glp-1 derivatives with helix-content exceeding 25 per cent, forming partially structured micellar-like aggregates
UA66861C2 (uk) 2-феніл-1-[4-(2-аміноетокси)бензил]індол в комбінації з естрогенами, способи лікування та продукт для лікування
MY127247A (en) New pharmaceutical composition
EP1203586A3 (en) Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin.
AU4806197A (en) Method and potentiated composition for treating migraine
WO2003006057A8 (en) Composition and method for the treatment of disease
AU3419995A (en) Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
HU0104300D0 (en) Method for assessing, improving or maintaining urogenital health in postmenopausal women
BR9406565A (pt) Variante de protease,processo de estabilização de uma variante de protease composição e aditivo detergentes
PL306173A1 (en) Novel inclusion complexes, method of obtaining them and pharmaceutical agent
NO20014101L (no) Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte
YU12903A (sh) Derivati aminoalkenilbenzoil-benzofurana ili benzotiopena, postupak za njihovo pripremanje i kompozicije koje ih sadrže
MY120524A (en) Part or jig for gas carburizing furnace
HU9601113D0 (en) Delta16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors, pharmaceutical compositions containing them and process for their production
WO2002004409A3 (en) Tetrahydrobenzothiazole analogues as neuroprotective agents
AP2002002470A0 (en) R 22 Replacement Refrigerant.
WO2001034172A3 (en) Methods and compositions for treating reward deficiency syndrome
WO2002043722A3 (en) Copper chelators for treating ocular inflammation
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
AU2001250662A1 (en) Sequestering
PL368505A1 (en) Prevention of addiction in pain management
WO2005046796A3 (en) Combinations of a cholesterol biosynthesis inhibitor and a soluble fiber for the treatment of conditions associated with elevated cholesterol levels
PT1276722E (pt) Inibidores de naftamidina-uroquinase